Evidence map›Paper›PMID 33753550›Full record

ArticleTobacco control2022

Characteristics and changes over time of nicotine vaping products used by vapers in the 2016 and 2018 ITC Four Country Smoking and Vaping Surveys.

Nicholas J Felicione, Brian Vincent Fix, Ann McNeill, K Michael Cummings, Maciej Lukasz Goniewicz, David Hammond, Ron Borland, Bryan W Heckman, Maansi Bansal-Travers, Shannon Gravely and 4 more

Open access · greenAbstract read
In one paragraph

Article in Tobacco control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Nicholas J FelicioneDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA nicholas.felicione@roswellpark.org.ORCID 0000-0001-9034-3477
Brian Vincent FixDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.ORCID 0000-0001-9135-4290
Ann McNeillDepartment of Addictions, King's College London, London, UK.ORCID 0000-0002-6223-4000
K Michael CummingsDepartment of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0002-7103-7017
Maciej Lukasz GoniewiczDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.ORCID 0000-0001-6748-3068
David HammondSchool of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada.
Ron BorlandSchool of Psychological Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
Bryan W HeckmanDepartment of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0003-4148-2467
Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Shannon GravelyDepartment of Psychology, University of Waterloo, Waterloo, Ontario, Canada.
Sara C HitchmanDepartment of Addictions, King's College London, London, UK.ORCID 0000-0001-6155-6916
David T LevyDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.ORCID 0000-0001-5280-3612
Geoffrey T FongDepartment of Psychology, University of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0001-9098-6472
Richard O'ConnorDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Roswell Park Comprehensive Cancer Center · USKing's College London · GBMedical University of South Carolina · USUniversity of Waterloo · CAGeorgetown University · USOntario Institute for Cancer Research · CAThe University of Melbourne · AU

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
CIHR FDN-148477NCI NIH HHS P01 CA200512
6 · The paper itself

Abstract

objectivesRegulation of nicotine vaping products (NVPs) varies between countries, impacting the availability and use of these products. This study updated the analyses of O'Connor

designData are from 4734 adult current vapers in Australia, Canada, England and the USA from Waves 1 (2016) and 2 (2018) of the International Tobacco Control Four Country Smoking and Vaping Survey. NVP characteristics included device description, adjustable voltage, nicotine content and tank size. Longitudinal analyses (n=1058) assessed movement towards or away from more complex/modifiable NVPs. A logistic regression was used to examine factors associated with changes in device description from 2016 to 2018.

resultsLike 2016, box-tanks were the most popular NVP (37.3%) in all four countries in 2018. Over 80% of vapers continued using the same NVP and nicotine content between waves, though movement tended towards more complex/modifiable devices (14.4% of vapers). Box-tank users, exclusive daily vapers and older vapers were most likely to continue using the same device description. Certain NVPs and features differed by country, such as higher nicotine contents in the USA (11.5% use 21+ mg/mL) and greater device stability over time in Australia (90.8% stability).

conclusionsMost vapers continued using the same vaping device and features over 18 months. Differences in NVP types and features were observed between countries, suggesting that differing NVP regulations affect consumer choices regarding the type of vaping device to use.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationVapingAdultHumansNicotineSmokersSmokingNicotineElectronic nicotine delivery devicesPublic policySurveillance and monitoring

Identifiers

PMID33753550
PMCPMC8455705
OpenAlexW3137708527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.